The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Recent advances in drug delivery systems for targeting cancer stem cells
Open accessAbstract
Cancer stem cells (CSCs) are a subpopulation of cancer cells with functions similar to those of normal stem cells. Although few in number, they are capable of self-renewal, unlimited proliferation, and multi-directional differentiation potential. In addition, CSCs have the ability to escape immune surveillance. Thus, they play an important role in the occurrence and development of tumors, and they are closely related to tumor invasion, metastasis, drug resistance, and recurrence after treatment. Therefore, specific targeting of CSCs may improve the efficiency of cancer therapy. A series of corresponding promising therapeutic strategies based on CSC targeting, such as the targeting of CSC niche, CSC signaling pathways, and CSC mitochondria, are currently under development. Given the rapid progression in this field and nanotechnology, drug delivery systems (DDSs) for CSC targeting are increasingly being developed. In this review, we summarize the advances in CSC-targeted DDSs. Furthermore, we highlight the latest developmental trends through the main line of CSC occurrence and development process; some considerations about the rationale, advantages, and limitations of different DDSs for CSC-targeted therapies were discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
MicroRNAs in Stress Signaling and Human Disease
Mendell, J. T., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.02.005 · Cited by 1,673
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Plaks, V., Kong, N., & Werb, Z. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.02.015 · Cited by 1,557
Interactions between cancer stem cells and their niche govern metastatic colonization
Malanchi, I., Santamaria-Martínez, A., Susanto, E., Peng, H., Lehr, H.-A., Delaloye, J.-F., & Huelsken, J. (2012) · Nature · doi:10.1038/nature10694 · Cited by 1,339
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Du, J.-Z., Du, X.-J., Mao, C.-Q., & Wang, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207150n · Cited by 1,172
Hiratsuka, S., Watanabe, A., Aburatani, H., & Maru, Y. (2006) · Nature Cell Biology · doi:10.1038/ncb1507 · Cited by 1,015
Tackling the cancer stem cells — what challenges do they pose?
Pattabiraman, D. R., & Weinberg, R. A. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4253 · Cited by 990
Mignotte, B., & Vayssiere, J. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2520001.x · Cited by 870
Metabolic control of autophagy
Galluzzi, L., Pietrocola, F., Levine, B., & Kroemer, G. (2014) · Cell · doi:10.1016/j.cell.2014.11.006 · Cited by 855
Understanding and targeting cancer stem cells: therapeutic implications and challenges
Chen, K., Huang, Y.-H., & Chen, J.-L. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.27 · Cited by 608
Understanding cancer stem cell heterogeneity and plasticity
Tang, D. G. (2012) · Cell Research · doi:10.1038/cr.2012.13 · Cited by 563
Cancer stem cell niche: the place to be
Borovski, T., De Sousa E Melo, F., Vermeulen, L., & Medema, J. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3220 · Cited by 518
Wang, L., Liu, Y., Li, W., Jiang, X., Ji, Y., Wu, X., Xu, L., Qiu, Y., Zhao, K., Wei, T., et al. (2011) · Nano Letters · doi:10.1021/nl103992v · Cited by 514
Self-citationCancer epigenetics: Moving forward
Nebbioso, A., Tambaro, F. P., Dell’Aversana, C., & Altucci, L. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007362 · Cited by 480
Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance
Chang, J. C. (2016) · Medicine · doi:10.1097/md.0000000000004766 · Cited by 435
Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment.
Bradford, G. B., Williams, B., Rossi, R., & Bertoncello, I. (1997) · PubMed · Cited by 419
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications
Nazio, F., Bordi, M., Cianfanelli, V., Locatelli, F., & Cecconi, F. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-019-0292-y · Cited by 388
Mitochondrial Regulation in Pluripotent Stem Cells
Xu, X., Duan, S., Yi, F., Ocampo, A., Liu, G.-H., & Izpisua Belmonte, J. C. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.005 · Cited by 374
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
Schonberg, D. L., Miller, T. E., Wu, Q., Flavahan, W. A., Das, N. K., Hale, J. S., Hubert, C. G., Mack, S. C., Jarrar, A. M., Karl, R. T., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.002 · Cited by 349
Role of integrated cancer nanomedicine in overcoming drug resistance
Iyer, A. K., Singh, A., Ganta, S., & Amiji, M. M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.012 · Cited by 343
Efficient and targeted delivery of siRNA in vivo
Shim, M. S., & Kwon, Y. J. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07904.x · Cited by 309
Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction
Das, B., Tsuchida, R., Malkin, D., Koren, G., Baruchel, S., & Yeger, H. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0724 · Cited by 309
Increased nanoparticle penetration in collagenase-treated multicellular spheroids.
Goodman, T. T., Olive, P. L., & Pun, S. H. (2007) · PubMed Central · Cited by 306
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S. M., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 258
Yang, Y.-P., Chien, Y., Chiou, G.-Y., Cherng, J.-Y., Wang, M.-L., Lo, W.-L., Chang, Y.-L., Huang, P.-I., Chen, Y.-W., Shih, Y.-H., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.071 · Cited by 240
Gelatti, A. C. Z., Drilon, A., & Santini, F. C. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.09.017 · Cited by 220
Mirza, Z., & Karim, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.020 · Cited by 219
Wang, H., Agarwal, P., Zhao, S., Xu, R. X., Yu, J., Lu, X., & He, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.048 · Cited by 218
Sizing up miRNAs as cancer genes
Caldas, C., & Brenton, J. D. (2005) · Nature Medicine · doi:10.1038/nm0705-712 · Cited by 202
Zhang, Y., Zhang, H., Wang, X., Wang, J., Zhang, X., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.072 · Cited by 194
Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells
Wang, X., Low, X. C., Hou, W., Abdullah, L. N., Toh, T. B., Mohd Abdul Rashid, M., Ho, D., & Chow, E. K.-H. (2014) · ACS Nano · doi:10.1021/nn503491e · Cited by 193
Ke, X.-Y., Lin Ng, V. W., Gao, S.-J., Tong, Y. W., Hedrick, J. L., & Yang, Y. Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.049 · Cited by 185
Arabi, L., Badiee, A., Mosaffa, F., & Jaafari, M. R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.044 · Cited by 183
Muntimadugu, E., Kumar, R., Saladi, S., Rafeeqi, T. A., & Khan, W. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.03.075 · Cited by 181
Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds
Sun, T.-M., Wang, Y.-C., Wang, F., Du, J.-Z., Mao, C.-Q., Sun, C.-Y., Tang, R.-Z., Liu, Y., Zhu, J., Zhu, Y.-H., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.011 · Cited by 174
Self-citationSun, R., Liu, Y., Li, S.-Y., Shen, S., Du, X.-J., Xu, C.-F., Cao, Z.-T., Bao, Y., Zhu, Y.-H., Li, Y.-P., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.018 · Cited by 172
Self-citationLiang, S., Li, C., Zhang, C., Chen, Y., Xu, L., Bao, C., Wang, X., liu, G., zhang, F., & Cui, D. (2015) · Theranostics · doi:10.7150/thno.11632 · Cited by 167
Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications
Lau, E. Y.-T., Ho, N. P.-Y., & Lee, T. K.-W. (2017) · Stem Cells International · doi:10.1155/2017/3714190 · Cited by 167
Lang, T., Liu, Y., Zheng, Z., Ran, W., Zhai, Y., Yin, Q., Zhang, P., & Li, Y. (2019) · Advanced Materials · doi:10.1002/adma.201806202 · Cited by 165
Self-citationLopez-Bertoni, H., Kozielski, K. L., Rui, Y., Lal, B., Vaughan, H., Wilson, D. R., Mihelson, N., Eberhart, C. G., Laterra, J., & Green, J. J. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00390 · Cited by 164
Li, X.-Y., Zhao, Y., Sun, M.-G., Shi, J.-F., Ju, R.-J., Zhang, C.-X., Li, X.-T., Zhao, W.-Y., Mu, L.-M., Zeng, F., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.049 · Cited by 163
Mittal, A., Chitkara, D., Behrman, S. W., & Mahato, R. I. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.053 · Cited by 161
Shi, S., Han, L., Deng, L., Zhang, Y., Shen, H., Gong, T., Zhang, Z., & Sun, X. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.005 · Cited by 158
Shen, H., Shi, S., Zhang, Z., Gong, T., & Sun, X. (2015) · Theranostics · doi:10.7150/thno.10804 · Cited by 158
Yang, Z., Sun, N., Cheng, R., Zhao, C., Liu, Z., Li, X., Liu, J., & Tian, Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.013 · Cited by 158
Zhou, Y., Zhou, W., Chen, X., Wang, Q., Li, C., Chen, Q., Zhang, Y., Lu, Y., Ding, X., & Jiang, C. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.11.013 · Cited by 158
Hu, K., Zhou, H., Liu, Y., Liu, Z., Liu, J., Tang, J., Li, J., Zhang, J., Sheng, W., Zhao, Y., et al. (2015) · Nanoscale · doi:10.1039/c5nr01084e · Cited by 153
Self-citationKesharwani, P., Banerjee, S., Padhyé, S., Sarkar, F. H., & Iyer, A. K. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00941 · Cited by 152
Cancer stem cells: therapeutic implications and perspectives in cancer therapy
Han, L., Shi, S., Gong, T., Zhang, Z., & Sun, X. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.02.006 · Cited by 150
Chiou, G., Cherng, J., Hsu, H., Wang, M., Tsai, C., Lu, K., Chien, Y., Hung, S., Chen, Y., Wong, C.-I., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.014 · Cited by 146
Yao, H.-J., Zhang, Y., Sun, L., & Liu, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.07.033 · Cited by 144
Self-citationChen, B., Dai, W., Mei, D., Liu, T., Li, S., He, B., He, B., Yuan, L., Zhang, H., Wang, X., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.09.014 · Cited by 142
Liang, D. H., Choi, D. S., Ensor, J., Kaipparettu, B. A., Bass, B. L., & Chang, J. C. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.002 · Cited by 141
Ma, X., Zhou, J., Zhang, C.-X., Li, X., Li, N., Ju, R.-J., Shi, J., Sun, M., Zhao, W., Mu, L.-M., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.066 · Cited by 140
Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
Dianat-Moghadam, H., Heidarifard, M., Jahanban-Esfahlan, R., Panahi, Y., Hamishehkar, H., Pouremamali, F., Rahbarghazi, R., & Nouri, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.043 · Cited by 140
Epigenetics of cancer stem cells: Pathways and therapeutics
Shukla, S., & Meeran, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.09.017 · Cited by 135
Nanomedicine-mediated cancer stem cell therapy
Shen, S., Xia, J., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.037 · Cited by 133
Yi, Y., Kim, H. J., Zheng, M., Mi, P., Naito, M., Kim, B. S., Min, H. S., Hayashi, K., Perche, F., Toh, K., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.006 · Cited by 131
A concise review on cancer treatment methods and delivery systems
Bidram, E., Esmaeili, Y., Ranji‐Burachaloo, H., Al-Zaubai, N., Zarrabi, A., Stewart, A. G., & Dunstan, D. E. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101350 · Cited by 131
Zhang, L., Yao, H.-J., Yu, Y., Zhang, Y., Li, R., Ju, R.-J., Wang, X., Sun, M., Shi, J., & Lü, W.-L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.055 · Cited by 129
Zhao, Y., Dong, Q., Li, J., Zhang, K., Qin, J., Zhao, J., Sun, Q., Wang, Z., Wartmann, T., Jauch, K. W., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.002 · Cited by 129
Nanoparticles-mediated reoxygenation strategy relieves tumor hypoxia for enhanced cancer therapy
Wang, H., Li, J., Wang, Y., Gong, X., Xu, X., Wang, J., Li, Y., Sha, X., & Zhang, Z. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.028 · Cited by 129
Zuo, Z.-Q., Chen, K., Yu, X., Zhao, G., Shen, S., Cao, Z., Luo, Y., Wang, Y., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.014 · Cited by 127
Targeting autophagy in cancer stem cells as an anticancer therapy
Lei, Y., Zhang, D., Yu, J., Dong, H. F., Zhang, J., & Yang, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.012 · Cited by 127
Role of microRNAs in maintaining cancer stem cells
Garofalo, M., & Croce, C. M. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.014 · Cited by 122
Modulation of the Tumor Microenvironment for Cancer Treatment: A Biomaterials Approach
Adjei, I. M., & Sharma, B. (2015) · Journal of Functional Biomaterials · doi:10.3390/jfb6010081 · Cited by 117
Li, H., Yan, W., Suo, X., Peng, H., Yang, X., Li, Z., Zhang, J., & Liu, D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.048 · Cited by 117
Fonseca, N. A., Rodrigues, A. S., Rodrigues‐Santos, P., Alves, V., Gregório, A. C., Valério-Fernandes, Â., Gomes-da-Silva, L. C., Rosa, M. S., Moura, V., Ramalho‐Santos, J., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.007 · Cited by 115
Kaushik, N. K., Kaushik, N., Yoo, K. C., Uddin, M. N., Kim, J. S., Lee, S., & Choi, E. H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.014 · Cited by 115
Mamaeva, V., Niemi, R., Beck, M., Özliseli, E., Desai, D., Landor, S. K.-J., Grönroos, T. J., Kronqvist, P., Pettersen, I. K. N., McCormack, E., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.42 · Cited by 115
Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles
Ning, S.-T., Lee, S., Wei, M., Peng, C., Lin, S. Y.-F., Tsai, M.-H., Lee, P., Shih, Y., Lin, C., Luo, T., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b04403 · Cited by 115
Li, Y., Xiao, Y., Lin, H.-P., Reichel, D., Bae, Y., Lee, E. Y., Jiang, Y., Huang, X., Yang, C., & Wang, Z. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.019 · Cited by 115
Sun, R., Shen, S., Zhang, Y., Xu, C., Cao, Z., Wen, L., & Wang, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.038 · Cited by 113
The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells
Joshi, P., Chakraborti, S., Ramı́rez-Vick, J. E., Ansari, Z. A., Shanker, V., Chakrabarti, P., & Singh, S. P. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.02.039 · Cited by 111
Mahira, S., Kommineni, N., Husain, G. M., & Khan, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.145 · Cited by 111
Cancer stem cells: markers or biomarkers?
Woodward, W. A., & Sulman, E. P. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9130-2 · Cited by 106
Wang, D., Huang, J., Wang, X., Yu, Y., Zhang, H., Chen, Y., Liu, J., Sun, Z., Zou, H. L., Sun, D., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.042 · Cited by 103
Wang, H., Agarwal, P., Zhao, S., Yu, J., Lu, X., & He, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.030 · Cited by 100
Ren, Y. T., Wang, R., Gao, L., Li, K., Zhou, X., Guo, H., Liu, C., Han, D., Tian, J., Ye, Q., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.008 · Cited by 98
Liu, J., Meng, T., Ming, Y., Wen, L., Cheng, B., Liu, N., Huang, X., Hong, Y. K., Yuan, H., & Hu, F. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s111647 · Cited by 98
Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance
Najafi, M., Mortezaee, K., & Ahadi, R. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.05.076 · Cited by 97
Miller‐Kleinhenz, J. M., Guo, X., Qian, W., Zhou, H., Bozeman, E. N., Zhu, L., Ji, X., Wang, Y. A., Styblo, T. M., O'Regan, R. M., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.035 · Cited by 96
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
Xiang, D., Shigdar, S. L., Bean, A. G. D., Bruce, M. P., Yang, W. R., Mathesh, M., Wang, T., Yin, W., Tran, P. H. L., Shamaileh, H. A., et al. (2017) · Theranostics · doi:10.7150/thno.20168 · Cited by 92
Sun, T., Wang, Y., Wang, Y., Xu, J., Zhao, X., Vangveravong, S., Mach, R. H., & Younan Xia, A. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400026 · Cited by 85
Chloroquine and nanoparticle drug delivery: A promising combination
Pelt, J., Busatto, S., Mauro Ferrari, B., Thompson, E. A., Mody, K., & Wolfram, J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.007 · Cited by 84
Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche
Boesch, M., Sopper, S., Zeimet, A. G., Reimer, D., Gastl, G. A., Ludewig, B., & Wolf, D. G. F. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.003 · Cited by 81
Delivery of bortezomib with nanoparticles for basal-like triple-negative breast cancer therapy
Shen, S., Du, X., Liu, J., Sun, R., Zhu, Y., & Wang, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.043 · Cited by 80
Wang, J., Lei, Z., Guo, Y., Wang, T., Qin, Z., Xiao, H., Fan, L., Chen, D., Bian, X., Liu, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5635 · Cited by 78
Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses
Dashti, A., Ebrahimi, M., Hadjati, J., Memarnejadian, A., & Moazzeni, S. M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.021 · Cited by 78
Li, Y., Shi, S., Ming, Y., Wang, L., Li, C., Luo, M., Li, Z., Li, B., & Chen, J. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0424-4 · Cited by 76
Oak, P., Kopp, F. B., Thakur, C., Ellwart, J. W., Rapp, U. R., Ullrich, A., Wagner, E., Knyazev, P. G., & Roidl, A. (2012) · International Journal of Cancer · doi:10.1002/ijc.27595 · Cited by 75
Chen, F., Zeng, Y., Qi, X., Chen, Y., Ge, Z., Jiang, Z., Zhang, X., Dong, Y., Chen, H., & Yu, Z. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.05.015 · Cited by 75
Targeting molecular pathways in cancer stem cells by natural bioactive compounds
Cianciosi, D., Varela‐López, A., Forbes-Hernández, T. Y., Gasparrini, M., Afrin, S., Reboredo‐Rodríguez, P., Zhang, J., Quiles, J. L., Nabavi, S. F., Battino, M. A., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.006 · Cited by 75
Advances in cancer stem cell targeting: How to strike the evil at its root
Pützer, B. M., Solanki, M., & Herchenröder, O. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.013 · Cited by 74
Verma, R. K., Yu, W., Singh, S. P., Shankar, S., & Srivastava, R. K. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.07.001 · Cited by 73
Jang, E., Kim, E., Son, H. Y., Lim, E., Lee, H., Choi, Y., Park, K., Han, S., Suh, J., Huh, Y., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.036 · Cited by 73
Faraj, A. A., Shaik, A. S., Ratemi, E., & Halwani, R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.053 · Cited by 72
Kinoh, H., Miura, Y., Chida, T., Liu, X., Mizuno, K., Fukushima, S., Morodomi, Y., Nishiyama, N., Cabral, H., & Kataoka, K. (2016) · ACS Nano · doi:10.1021/acsnano.6b00900 · Cited by 72
Lin, F., Wen, D., Wang, X., & Mahato, R. I. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.036 · Cited by 72
Skoda, J., Borankova, K., Jansson, P. J., Huang, M., Veselská, R., & Richardson, D. R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.020 · Cited by 72
Zhao, Y., Alakhova, D. Y., Zhao, X., Band, V., Batrakova, E. V., & Kabanov, A. V. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102124 · Cited by 71
Basak, S. K., Zinabadi, A., Wu, A. W., Venkatesan, N., Duarte, V. M., Kang, J. J., Dalgard, C. L., Srivastava, M., Sarkar, F. H., Wang, M. B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4181 · Cited by 70
Satapathy, S. R., Nayak, A., Siddharth, S., Das, S., Nayak, D., & Kundu, C. N. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.01.007 · Cited by 70
Involvement of hyaluronan and CD44 in cancer and viral infections
Heldin, P., Kolliopoulos, C., Lin, C., & Heldin, C. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109427 · Cited by 69
Yang, R., Mondal, G., Wen, D., & Mahato, R. I. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.07.017 · Cited by 68
Kim, D., Kim, M., Park, H.-B., Kim, K., & Kim, D.-E. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00705 · Cited by 68
Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer
Wen, D., Peng, Y., Feng, L., Singh, R. K., & Mahato, R. I. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2355 · Cited by 67
Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer
Dimou, A., Syrigos, K. N., & Saif, M. W. (2012) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834012446008 · Cited by 66
Debele, T. A., Yu, L.-Y., Yang, C.-S., Shen, Y., & Lo, C.-L. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00856 · Cited by 66
Mimeault, M., & Batra, S. K. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.08.001 · Cited by 65
Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells
Han, Shin, D. H., Kim, J. S., Weon, K. Y., Jang, C.-Y., & Kim, J.-S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s95850 · Cited by 65
Mitochondrial biology in cancer stem cells
Loureiro, R., Mesquita, K. A., Novais, S. M., Oliveira, P. J., & Vega‐Naredo, I. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.012 · Cited by 64
Multifunctional "core-shell" nanoparticles-based gene delivery for treatment of aggressive melanoma
Li, L., Song, L., Yang, X., Li, X., Wu, Y., He, T., Wang, N., Yang, S., Zeng, Y., Yang, L., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.019 · Cited by 62
Wu, P., Liu, Q., Wang, Q., Qian, H., Yu, L., Liu, B., & Li, R. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s166104 · Cited by 59
Kim, K. G., Liu, Y., Li, S., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500754r · Cited by 58
Self-citationDevelopment and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133
Bourseau-Guilmain, E., Bejaud, J., Griveau, A., Lautram, N., Hindré, F., Weyland, M., Benoît, J., & Garcion, E. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.06.001 · Cited by 57
Ma, J., Kala, S., Yung, S., Chan, T. M., Cao, Y., Jiang, Y., Liu, X., Giorgio, S., Peng, L., & Wong, A. S. T. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.006 · Cited by 56
Huang, W.-T., Larsson, M., Lee, Y.-C., Liu, D., & Chiou, G. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.014 · Cited by 54
Self-citationZhou, Y., Yang, J., Rhim, J. S., & Kopeček, J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.005 · Cited by 53
Zeng, Y.-B., Yu, Z., He, Y., Zhang, T., Du, L., Dong, Y., Chen, H., Zhang, Y., & Wang, W. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.166 · Cited by 52
Karandish, F., Froberg, J., Borowicz, P. P. P., Wilkinson, J. C., Choi, Y., & Mallik, S. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.12.036 · Cited by 52
Andey, T. A., Marepally, S. K., Patel, A. R., Jackson, T., Sarkar, S., O’Connell, M. R., Reddy, R. C., Chellappan, S., Singh, P., & Singh, M. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.049 · Cited by 51
Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer
Uz, M., Kalaga, M., Pothuraju, R., Ju, J., Junker, W. M., Batra, S. K., Mallapragada, S. K., & Rachagani, S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.031 · Cited by 51
Tsai, P., Wang, M., Chang, J.-H., Yarmishyn, A. A., Nguyen, P. N. N., Chen, W., Chien, Y., Huo, T., Mou, C., & Chiou, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b04474 · Cited by 51
Ahmad, A., Mondal, S. K., Mukhopadhyay, D., Banerjee, R., & Alkharfy, K. M. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00900 · Cited by 49
Nascimento, T. L., Hillaireau, H., Vergnaud, J., Rivano, M., Deloménie, C., Courilleau, D., Arpicco, S., Suk, J. S., Hanes, J. S., & Fattal, E. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.125 · Cited by 49
Shen, S., Sun, C., Du, X., Li, H., Liu, Y., Xia, J., Zhu, Y., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.026 · Cited by 47
Self-citationLi, J., Xu, W., Yuan, X., Chen, H., Song, H., Wang, B., & Han, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s144184 · Cited by 47
Mitochondria in pluripotent stem cells: stemness regulators and disease targets
Folmes, C. D. L., Ma, H., Mitalipov, S. M., & Terzic, A. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.02.001 · Cited by 46
Усачева, М. Н., Swaminathan, S. K., Kirtane, A. R., & Panyam, J. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5003619 · Cited by 46
Miyano, K., Cabral, H., Miura, Y., Matsumoto, Y., Mochida, Y., Kinoh, H., Iwata, C., Nagano, O., Saya, H., Nishiyama, N., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.021 · Cited by 45
Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers
Mokhtarzadeh, A., Hassanpour, S., Vahid, Z. F., Hejazi, M., Hashemi, M., Ranjbari, J., Tabarzad, M., Noorolyai, S., & de la Guárdia, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.028 · Cited by 45
Zhang, X., Liu, Y., Kim, K. G., Mac, J., Zhuang, R., & Wang, P. (2017) · RSC Advances · doi:10.1039/c7ra01100h · Cited by 43
Self-citationShin, J., Shin, D. H., & Kim, J. S. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.03.001 · Cited by 43
Cancer stem cell-targeted therapeutics and delivery strategies
Ahmad, G., & Amiji, M. M. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1263615 · Cited by 42
Yang, Q., Zhang, T., Wang, C., Jiao, J., Li, J., & Deng, Y. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.10.006 · Cited by 41
Rafael, D. F. D. S., Gener, P., Andrade, F., Seras‐Franzoso, J., Montero, S., Fernández, Y., Hidalgo, M. M., Arango, D., Sayós, J., Florindo, H. F., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1461276 · Cited by 41
Current report of natural product development against breast cancer stem cells
Hermawan, A., & Putri, H. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.09.012 · Cited by 40
Zhao, P., Xia, G., Dong, S., Jiang, Z., & Chen, M. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.032 · Cited by 39
Zhang, J., Kinoh, H., Hespel, L., Liu, X., Quader, S., Martin, J. D., Chida, T., Cabral, H., & Kataoka, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.025 · Cited by 39
Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells
Huang, X., Huang, J., Leng, D., Yang, S., Qi, Y., Sun, J., & Hu, J. (2017) · World Journal of Surgical Oncology · doi:10.1186/s12957-017-1230-4 · Cited by 39
Yang, T., Chen, Y., Zhao, P., Xue, H., You, J., Li, B., Liu, Y., He, C., Zhang, X., Fan, L., et al. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.05.012 · Cited by 39
Self-citationSun, N., Zhao, C., Cheng, R., Liu, Z., Li, X., Lu, A., Tian, Z., & Yang, Z. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00367 · Cited by 39
Li, C., Liang, Y., Cao, J., Zhang, N., Wei, X., Tu, M., Xu, F., & Xu, Y. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.06.013 · Cited by 39
A novel double-targeted nondrug delivery system for targeting cancer stem cells
Qiao, S., Zhao, Y., Geng, S., Li, Y., Hou, X., Liu, Y., Lin, F., Yao, L., & Tian, W. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s116230 · Cited by 35
Self-citationChen, Z., Zhu, P., Zhang, Y., Liu, Y., He, Y., Zhang, L., & Gao, Y. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00352 · Cited by 34
Self-citationExisting drugs and their application in drug discovery targeting cancer stem cells
Lv, J., & Shim, J. S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0628-1 · Cited by 29
Li, L., Cui, D., Ye, L., Li, Y., Zhu, L., Yang, L., Bai, B., Nie, Z., Gao, J., & Cao, Y. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000541 · Cited by 29
Li, W., Yan, R., Liu, Y., He, C., Zhang, X., Lu, Y., Khan, M. W., Xu, C., Yang, T., & Xiang, G. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1645244 · Cited by 28
Self-citationCationic lipoplexes for treatment of cancer stem cell-derived murine lung tumors
Andey, T. A., Bora-Singhal, N., Chellappan, S., & Singh, M. S. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.02.007 · Cited by 25
Immunotherapies for bladder cancer: a new hope
Fakhrejahani, F., Tomita, Y., Maj‐Hes, A., Trepel, J. B., Santis, M. D., & Apolo, A. B. (2015) · Current Opinion in Urology · doi:10.1097/mou.0000000000000213 · Cited by 23
Biomaterials to suppress cancer stem cells and disrupt their tumoral niche
García-Mazás, C., Csaba, N., & García-Fuentes, M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.013 · Cited by 22
Yang, M., Chen, M.-T., Huang, P., Wang, C., Chang, Y.-C., Yang, Y., Lo, W., Sung, W.-H., Liao, Y., Lee, Y., et al. (2014) · Cell Transplantation · doi:10.3727/096368914x682107 · Cited by 20
Liang, D.-S., Liu, J., Peng, T., Peng, H. C., Guo, F., & Zhong, H. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.08.063 · Cited by 20
Suh, J. S., Lee, H. J., Nam, H., Jo, B. S., Lee, D. W., Kim, J., Lee, J. Y., Chung, C. P., Lee, G. T., & Park, Y. J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.148 · Cited by 19
Guo, X. D., Guo, N., Zhao, J., & Cai, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.5829 · Cited by 15
El‐Ashmawy, N. E., El-Zamarany, E. A., Salem, M. L., Khedr, E. G., & Ibrahim, A. O. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.04.001 · Cited by 13
Shi, F., Li, M., Wu, S., Yang, F., Wu, D., Pan, M., Zhao, F., Luo, S., Gu, N., & Dou, J. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.02.014 · Cited by 12
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Chen, L., Yang, F., Chen, S., & Tai, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.995882 · Cited by 60
Metadata
- Authors
- Duan, H., Liu, Y., Gao, Z., & Huang, W.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 11
- Issue
- 1
- Pages
- 55-70
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3090554353
- Cited by
- 256
- References
- 164
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.